Abstract
Inducible nitric oxide synthase (iNOS) expression is regulated at both the transcriptional and post-transcriptional level in epithelial cells. The aim of this study was to characterize the effects of tyrosine phosphorylation on iNOS activity. In a human intestinal epithelial cell line stimulated with cytokines, tyrosine phosphorylation of human iNOS protein was observed after 30 min exposure to pervanadate (PV), an inhibitor of protein tyrosine phosphatases. 4-Amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine, a specific inhibitor of Src tyrosine kinases, abolished the PV-induced iNOS tyrosine phosphorylation. Cotransfection of Src with iNOS cDNA in human embryonic kidney (HEK) 293 cells resulted in a threefold (P<0.001) increase of iNOS protein levels and tyrosine phosphorylation of iNOS. In the presence of Src, 76% of wild-type (wt) iNOS was redistributed to detergent-insoluble domains and iNOS activity was decreased by 28% (P<0.05) despite increased iNOS protein levels. Analysis of iNOS tyrosine mutants revealed decreased Src-induced effects in Y151F iNOS mutant. Using a GST-fusion protein containing a domain encompassing Y151, we show that Y151 is a direct substrate for active Src in vitro. These findings indicate a role for iNOS tyrosine phosphorylation in the regulation of iNOS activity and the implication of Src tyrosine kinases in this pathway.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Abram CL, Courtneidge SA . (2000). Exp Cell Res 254: 1–13.
Albakri QA, Stuehr DJ . (1996). J Biol Chem 271: 5414–5421.
Ambs S, Merriam WG, Bennett WP, Felley-Bosco E, Ogunfusika MO, Oser SM et al. (1998). Cancer Res 58: 334–341.
Andre M, Felley-Bosco E . (2003). FEBS Lett 546: 223–227.
Andre M, Latado H, Felley-Bosco E . (2005). Biochem Pharmacol 69: 595–602.
Baek KJ, Thiel BA, Lucas S, Stuehr DJ . (1993). J Biol Chem 268: 21120–21129.
Chiu T, Wu SS, Santiskulvong C, Tangkijvanich P, Yee Jr HF, Rozengurt E . (2002). Am J Physiol Cell Physiol 282: C434–C450.
Cobbs CS, Brenman JE, Aldape KD, Bredt DS, Israel MA . (1995). Cancer Res 55: 727–730.
Espey MG, Miranda KM, Pluta RM, Wink DA . (2000). J Biol Chem 275: 11341–11347.
Felley-Bosco E, Ambs S, Lowenstein CJ, Keefer LK, Harris CC . (1994). Am J Respir Cell Mol Biol 11: 159–164.
Felley-Bosco E, Bender FC, Courjault-Gautier F, Bron C, Quest AFG . (2000). Proc Natl Acad Sci USA 97: 14334–14339.
Feng X, Guo Z, Nourbakhsh M, Hauser H, Ganster R, Shao L et al. (2002). Proc Natl Acad Sci USA 99: 14212–14217.
Fischman TO, Hruza A, Da Niu X, Fossetta JD, Lunn CA, Dolphin E et al. (1999). Nat Struct Biol 6: 233–242.
Giepmans BN, Hengeveld T, Postma FR, Moolenaar WH . (2001). J Biol Chem 276: 8544–8549.
Hanke JH, Gardner JP, Sow RL, Changelian PS, Brissette WH, Weringer EJ et al. (1996). J Biol Chem 271: 695–701.
Huyer G, Liu S, Kelly J, Moffat J, Payette P, Kennedy B et al. (1997). J Biol Chem 272: 843–851.
Irby RB, Yeatman TJ . (2000). Oncogene 19: 5636–5642.
Keely SJ, Calandrella SO, Barrett KE . (2000). J Biol Chem 275: 12619–12625.
Kimura H, Miura S, Shigematsu T, Ohkubo N, Tsuzuki Y, Kurose I et al. (1997). Dig Dis Sci 42: 1047–1054.
Kolodziejski PJ, Musial A, Koo JS, Eissa NT . (2002). Proc Natl Acad Sci USA 99: 12315–12320.
Kroncke KD, Fehsel K, Kolb-Bachofen V . (1998). Clin Exp Immunol 113: 147–156.
Latour S, Veillette A . (2001). Curr Opin Immunol 13: 299–306.
Lee J, Ryu H, Ferrante RJ, Morris Jr SM, Ratan RR . (2003). Proc Natl Acad Sci USA 100: 4843–4848.
MacMicking J, Xie QW, Nathan C . (1997). Annu Rev Immunol 15: 323–350.
Mariner DJ, Anastasiadis P, Keilhack H, Bohmer FD, Wang J, Reynolds AB . (2001). J Biol Chem 276: 28006–28013.
Miller MJS, Sandoval M . (1999). Am J Physiol 276: G795–G799.
Musial A, Eissa NT . (2001). J Biol Chem 276: 24268–24273.
Navarro-Lerida I, Corvi MM, Barrientos AA, Gavilanes F, Berthiaume LG, Rodriguez-Crespo I . (2004). J Biol Chem 279: 55682–55689.
Paccani SR, Patrussi L, Ulivieri C, Masferrer JL, D'Elios MM, Baldari CT . (2005). Blood 105: 2042–2048.
Pan J, Burgher KL, Szczepanik AM, Ringheim GE . (1996). Biochem J 314: 889–894.
Posner B, Faure R, Burgess J, Bevan A, Lachance D, Sun G et al. (1994). J Biol Chem 269: 4596–4604.
Rachmilewitz D, Stamler JS, Bachwich D, Karmeli F, Ackerman Z, Podolski DK . (1995). Gut 36: 718–723.
Ratovitski EA, Alam MR, Quick RA, McMillan A, Bao C, Kozlovsy C et al. (1999a). J Biol Chem 274: 993–999.
Ratovitski EA, Bao C, Quick RA, McMillan A, Kozlovsky C, Lowenstein CJ . (1999b). J Biol Chem 274: 30250–30257.
Rumbo M, Courjault-Gautier F, Sierro F, Sirard JC, Felley-Bosco E . (2005). FEBS J 272: 444–453.
Salh B, Wagey R, Marotta A, Tao JS, Pelech S . (1998). J Immunol 161: 6947–6954.
Sayle RA, Milner-White EJ . (1995). Trends Biochem Sci 20: 374.
Singer II, Kawka DW, Scott S, Weidner JR, Mumford RA, Riehl TE et al. (1996). Gastroenterology 111: 871–885.
Sondermann H, Kuriyan J . (2005). Cell 121: 158–160.
Songyang Z, Cantley LC . (1995). Trends Biochem Sci 20: 470–475.
Taylor BS, deVera ME, Ganster RW, Wang Q, Shapiro RA, Morris SM et al. (1998). J Biol Chem 273: 15148–15156.
Thomsen LL, Miles DW, Happerfield L, Bobrow LG, Knowles RG, Moncada S . (1995). Br J Cancer 72: 41–44.
Vecchini F, Pringault E, Billiar TR, Geller DA, Hausel P, Felley-Bosco E . (1997). Cell Growth Differ 8: 261–268.
Vodovotz Y, Russell D, Xie Q, Bogdan C, Nathan C . (1995). J Immunol 154: 2914–2925.
Acknowledgements
We thank J Dall'Aglio for his skillful assistance, Drs JR Weidner, W Moolenaar and C Baldari for their generous gift of the anti-human iNOS antiserum and Src or Fyn encoding plasmids, Drs B Hemmings and D Diviani for suggestions and Drs B Thorens, M vanBemmelen and D Firsov for critical reading of the manuscript. This work was supported by the Swiss National Science Foundation (SNSF 3100A0-103928) and EC Grant QLRT2001-02357.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on Oncogene website (http://www.nature.com/onc).
Supplementary information
Rights and permissions
About this article
Cite this article
Hausel, P., Latado, H., Courjault-Gautier, F. et al. Src-mediated phosphorylation regulates subcellular distribution and activity of human inducible nitric oxide synthase. Oncogene 25, 198–206 (2006). https://doi.org/10.1038/sj.onc.1209030
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1209030